Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

DCX Systems jumps after Rs 18.28 crore orders from customers

Mumbai, Aug. 18 -- The company received orders worth Rs 15.19 crore for the manufacture and supply of cable and wire harness assemblies, comprising domestic and export orders. Raneal Advanced Systems... Read More

Cerrado Gold Inc. Profit Climbs In Q2

India, Aug. 18 -- Cerrado Gold Inc. (CERT.V) revealed earnings for its second quarter that Increased, from last year The company's bottom line came in at $8.41 million, or $0.07 per share. This compa... Read More

E Nusa Tenggara quake: Indonesia sets up 9 health ops centers

Jakarta, Aug. 18 -- Indonesia's Ministry of Health has activated nine emergency operations centers across East Nusa Tenggara following a major earthquake, prioritizing the rapid restoration of regiona... Read More

Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy ... Read More

Singapore Clinical Trial: Bepirovirsen Liver Biopsy study

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'Bepirovirsen Liver Biopsy study'. The following are the other relevant details related to the tria... Read More

Sensex slides 288 pts; realty shares decline

Mumbai, Aug. 18 -- The headline equity benchmarks traded with moderate losses in the morning trade, weighed down by a rise in crude oil prices following the expiry of the US-Iran ceasefire and growing... Read More

Singapore Clinical Trial: A single-ascending and multiple-ascending dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of LY4226695 in healthy participants.

Singapore, Aug. 18 -- The Health Sciences Authority received information related to the study titled 'A single-ascending and multiple-ascending dose study to evaluate the safety, tolerability, pharmac... Read More

• ««
• «
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• »
• »»